NCT01630876UnknownNot Applicable
Anatomic and Functional Outcomes of 23-gauge Vitrectomy Combined With Posterior Subtenon Triamcinolone Injection for the Treatment of Idiopathic Epiretinal Membrane
Yeungnam University College of Medicine2 sites in 1 country50 target enrollmentStarted: January 2012Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Enrollment
- 50
- Locations
- 2
- Primary Endpoint
- Changes of best corrected visual acuity and central retinal thickness
Study Overview
Brief Summary
This study compares the anatomical and visual outcomes of patients with idiopathic epiretinal membrane(ERM) treated by vitrectomy and membrane peeling with or without subtenon triamcinolone acetonide injection
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 20 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •1.The participant must have idiopathic epiretinal membrane 2.The participant must be willing and able to comply with the protocol.
Exclusion Criteria
- •The participant has idiopathic epiretinal membrane with other ocular vascular diseases such as Diabetes retinopathy, BRVO, etc.
- •The participant has any additional ocular diseases that have irreversibly compromised or could likely compromise the visual acuity of the study eye including amblyopia, anterior ischemic optic neuropathy, clinically significant diabetic macular edema, severe non proliferative diabetic retinopathy, or proliferative diabetic retinopathy.
- •The participant has had intraocular surgery (including lens replacement surgery).
- •The participant has a history of (within the last six months), or current ocular or periocular infection (including any history of ocular herpes zoster or simplex).
Outcomes
Primary Outcomes
Changes of best corrected visual acuity and central retinal thickness
Time Frame: 6 months
Changes of best corrected visual acuity and central retinal thickness on optical coherence tomography (OCT) at baseline and 1, 3, 6 months after injection
Secondary Outcomes
- Changes in status of ISOS line(6 months)
Investigators
Min Sagong
Assistant Professor
Yeungnam University College of Medicine
Study Sites (2)
Loading locations...
Similar Trials
Completed
Not Applicable
Epiretinal Macular Membrane and Cataract ExtractionEpiretinal Macular MembraneCataract ExtractionNCT00851760Centre Hospitalier Universitaire Dijon174
Terminated
Not Applicable
EpiRetinal Membrane Peeling and Internal Limiting MembraneMacular PuckerInternal Limiting MembraneEpiretinal MembraneNCT04802265University Hospital, Clermont-Ferrand10
Completed
Not Applicable
23-gauge Pars Plana Vitrectomy With Silicone Oil Injectionsilicone Oil Injection With SurgicalRetinal DetachmentNCT04280770Ain Shams University50
Completed
Not Applicable
Intravitreal Anti-VEGF in Exudative AMD With Epiretinal MembranesAge Related Macular DegenerationEpiretinal MembraneNCT01846351New England Retina Associates16
Completed
Not Applicable
Clinicopathologic Findings for Macular DiseaseMacular DiseaseNCT00994227Hallym University Medical Center60